Evaluating synergy of belinostat and ribociclib in triple-negative breast cancer 

April 27, 2020

Abstract Purpose: Triple Negative Breast Cancer (TNBC) has a poor prognosis due to higher rates of metastases and a lack of targeted treatments. Emerging targeted…